por
Gus Iversen, Editor in Chief | April 24, 2026
Royal Philips has received FDA 510(k) clearance for a set of CT imaging systems under its Rembra platform, expanding its portfolio across diagnostic imaging and radiation therapy planning.
The Amsterdam-based company said the clearance covers three systems: Rembra CT, Rembra RT and Areta RT. The products are intended to address rising imaging volumes and increasing complexity in both acute care and oncology settings.
Rembra CT is designed for high-throughput environments such as emergency departments and critical care units. The system features an 85 cm bore and is configured to support large imaging volumes, with Philips citing capacity for up to 270 exams per day. The platform is positioned to deliver rapid image acquisition and reconstruction while maintaining diagnostic quality in time-sensitive scenarios.
Ad Statistics
Times Displayed: 13590
Times Visited: 41 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
The Rembra platform also extends into radiation oncology. Rembra RT and Areta RT are built to support simulation and treatment planning workflows, incorporating wide field-of-view imaging and 4DCT capabilities. These features are intended to improve tumor targeting and reduce exposure to surrounding healthy tissue.
Philips said the systems are designed to integrate diagnostic imaging and radiation therapy workflows, allowing clinicians to move from initial assessment to treatment planning within a more unified environment. The approach reflects broader industry efforts to streamline imaging pathways and reduce variability in care delivery.
“As healthcare systems manage increasing demand and complexity, imaging plays a critical role in enabling timely and informed clinical decisions,” said Dan Xu, business leader of CT at Philips. “With the Rembra platform, we are redefining what clinicians can expect from CT, combining speed, scalability, and precision to expand access to high-quality imaging while supporting confident diagnosis and highly accurate treatment planning.”
The clearance adds to Philips’ existing CT portfolio and underscores ongoing investment in systems aimed at improving throughput and workflow coordination across care settings.
